Alge Daniel L, Santa Cruz Grace, Goebel W Scott, Chu Tien-Min Gabriel
Weldon School of Biomedical Engineering, Purdue University, West Lafayette, IN 47908, USA.
Biomed Mater. 2009 Apr;4(2):025016. doi: 10.1088/1748-6041/4/2/025016. Epub 2009 Apr 6.
Dicalcium phosphate dihydrate (DCPD) cements are typically prepared using beta-tricalcium phosphate (beta-TCP) as the base component. However, hydroxyapatite (HA) is an interesting alternative because of its potential for reducing cement acidity, as well as modulating cement properties via ionic substitutions. In the present study, we have characterized DCPD cements prepared with a novel formulation based on monocalcium phosphate monohydrate (MCPM) and HA. Cements were prepared using a 4:1 MCPM:HA molar ratio. The reactivity of HA in this system was verified by showing DCPD formation using poorly crystalline HA, as well as highly crystalline HA. Evaluation of cements prepared with poorly crystalline HA revealed that setting occurs rapidly in the MCPM/HA system, and that the use of a setting regulator is necessary to maintain workability of the cement paste. Compressive testing showed that MCPM/HA cements have strengths comparable to what has previously been published for DCPD cements. However, preliminary in vitro analysis of cement degradation revealed that conversion of DCPD to HA may occur much more rapidly in the MCPM/HA system compared to cements prepared with beta-TCP. Future studies should investigate this property further, as it could have important implications for the use of HA-based DCPD cement formulations.
二水磷酸二钙(DCPD)骨水泥通常以β-磷酸三钙(β-TCP)作为基础成分来制备。然而,羟基磷灰石(HA)是一种有趣的替代物,因为它有降低骨水泥酸度的潜力,还能通过离子取代来调节骨水泥的性能。在本研究中,我们对基于一水磷酸二氢钙(MCPM)和HA的新型配方制备的DCPD骨水泥进行了表征。骨水泥采用4:1的MCPM:HA摩尔比制备。通过使用结晶度差的HA以及高度结晶的HA来证明DCPD的形成,从而验证了HA在该体系中的反应活性。对用结晶度差的HA制备的骨水泥的评估表明,在MCPM/HA体系中凝固迅速发生,并且需要使用凝固调节剂来保持水泥浆的可加工性。压缩测试表明,MCPM/HA骨水泥的强度与先前发表的DCPD骨水泥的强度相当。然而,骨水泥降解的初步体外分析表明,与用β-TCP制备的骨水泥相比,在MCPM/HA体系中DCPD向HA的转化可能发生得更快。未来的研究应进一步探究这一特性,因为它可能对基于HA的DCPD骨水泥配方的使用具有重要意义。